Related Experiment Video
Updated: Jun 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Factors determining heterogeneity in coronary collateral development: A clinical perspective
Pier D Lambiase1, Michael S Marber
1Department of Cardiology, Rayne Institute, St Thomas' Hospital, Lambeth Palace Road, London, United Kingdom.
Abstract:
The mechanisms responsible for collateral development have attracted considerable attention in cellular and molecular research because these vessels have the capacity to protect against myocardial infarction and reduce exercise-induced ischemia. This has led to a number of phase I trials employing angiogenic peptides, genes and cell transplantation. However, there are significant differences in the degree of collateral development among patients even with similar patterns of coronary disease. Understanding the factors responsible for this heterogeneity has important implications for the efficacy of future therapeutic strategies. Therefore, this review will examine these factors from the clinical perspective integrating the clinical evidence with recent molecular and cellular studies. The role of specific pharmacological agents and novel investigational strategies will be discussed.
Insights
Collateral vessel development is key to protecting against heart attacks and ischemia. Understanding patient differences in this process is vital for improving future therapies.
Area of Science:
- Cardiovascular research
- Molecular and cellular biology
- Clinical medicine
Background:
- Collateral vessels protect against myocardial infarction and ischemia.
- Current therapeutic strategies include angiogenic peptides, genes, and cell transplantation.
- Significant patient variability exists in collateral development.
Purpose of the Study:
- To examine factors influencing collateral development heterogeneity in patients.
- To integrate clinical evidence with molecular and cellular research.
- To discuss implications for future therapeutic strategies.
Main Methods:
- Review of clinical evidence.
- Integration of recent molecular and cellular studies.
- Examination of factors affecting collateral development.
Main Results:
- Heterogeneity in collateral development is observed among patients with similar coronary disease.
- Understanding these differences is crucial for therapeutic efficacy.
- Specific pharmacological agents and novel strategies are under investigation.
Conclusions:
- Factors contributing to variability in collateral development require further investigation.
- This understanding is essential for optimizing therapeutic interventions.
- Future research should focus on personalized approaches to enhance collateralization.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
